| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | — | +0.0% |
| Cost of Revenue | $2.0M | — | +0.0% |
| Gross Profit | $13K | — | +0.0% |
| R&D Expense | $1.6M | — | -27.7% |
| SG&A Expense | $2.1M | — | -10.5% |
| Operating Income | -$3.7M | — | +18.7% |
| Pre-tax Income | $49.4M | — | +800.5% |
| Income Tax | $11.1M | — | +1805.8% |
| Net Income | $38.3M | — | +601.3% |
| EPS (Basic) | $0.94 | — | +594.7% |
| EPS (Diluted) | $0.91 | — | +578.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.2M | -71.3% | — |
| Short-term Investments | $5.0M | -8.3% | +34.4% |
| Current Assets | $68.2M | -48.9% | -48.2% |
| Total Assets | $268.8M | +16.5% | +82.2% |
| Current Liabilities | $10.6M | -44.7% | +92.3% |
| Stockholders' Equity | $238.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | — | +17.2% |
| Capital Expenditures | $5K | — | +66.7% |
| Investing Cash Flow | -$19.5M | — | -182.5% |
| Financing Cash Flow | -$10.4M | — | — |
| Free Cash Flow | -$2.9M | — | +17.1% |
| +69.2% |